|
|
Company Overview
Swiss Medica is a specialty pharmaceutical company focused on commercializing over-the-counter clinically- tested, patented all-natural products that relieve chronic ailments. Swiss Medica builds its brands through innovative and focused distribution and marketing strategies. Swiss Medica's mission is to be a world leader in the commercialization of over-the-counter, safe and effective chronic ailment treatments.
Swiss Medica's flagship product, the O24™ Pain Neutralizer, holds US Patent #6,444,238B1. The O24™ pain relief solution has been used and recommended for its fast-acting and long-lasting benefits by healthcare professionals and athletes in the United States, Canada and in Europe. O24™ is widely available over-the- counter throughout the United States and Canada in leading pharmacies and other retailers.
Swiss Medica has recently launched the patented O24 Fibromyalgia™ pain reliever (US Patent #6,444,238B1) over-the-counter in North American retailers. The National Fibromyalgia Association (NFA) recently awarded O24 Fibromyalgia™ their first NFA Seal of Approval. Over 10 million Americans suffer from the long-term pain associated with fibromyalgia. In a randomized double blind clinical trial conducted in 2005, 88 percent of the patients who used O24 Fibromyalgia™ reported mild to markedly better improvement, versus only 7 percent who used the placebo.
|
|